首页>
外国专利>
Use of inhibitors of the activation of CXCR4 receptor by SDF-1 in treating rheumatoid arthritis
Use of inhibitors of the activation of CXCR4 receptor by SDF-1 in treating rheumatoid arthritis
展开▼
机译:SDF-1激活CXCR4受体抑制剂在治疗类风湿关节炎中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
This invention provides a method for treating rheumatoid arthritis or other forms of inflammatory arthritis which comprises administering to a subject an amount of an agent effective to inhibit the activation of the CXCR4 receptor by SDF-1. This invention further provides a composition for treating rheumatoid arthritis comprising an effective amount of an agent capable of inhibiting the activation of the CXCR4 receptor by SDF-1 and a pharmaceutically acceptable carrier. This invention also provides a method for determining whether an agent is capable of inhibiting the activation of the CXCR4 receptor by SDF-1 comprising: (a) contacting cells expressing the CXCR4 receptor in the presence of SDF-1 with the agent under condition permitting activation of the CXCR4 receptor by SDF-1 if the agent is absent; and (b) determining whether the amount of activation of the CXCR4 receptor by SDF-1 is decreased in the presence of the agent relative to the amount of activation in its absence, such a decrease indicating that the agent is capable of inhibiting the activation of the CXCR4 receptor by SDF-1. Finally, this invention provides agents identified by such a method.
展开▼